share_log

Exicure | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Exicure | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Exicure | PRE 14A：并购重组委托声明
美股sec公告 ·  07/19 16:16
Moomoo AI 已提取核心信息
Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with...Show More
Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with the minimum bid price requirement and was given until September 9, 2024, to regain compliance. The company believes that the reverse stock split will improve the marketability and liquidity of its common stock. Stockholders of record as of July 26, 2024, will be entitled to vote at the Special Meeting. The company has also provided information on how stockholders can attend the virtual meeting and cast their votes.
总部位于伊利诺伊州芝加哥的生物技术公司Exicure, Inc. 宣布将于2024年8月15日以虚拟形式召开股东特别会议。会议的主要议程是征得股东批准修订公司修正章程，以实现普通股的股票拆分。所提议的股票拆分比率范围为1股转2股至1股转15股，具体比率由董事会自行决定。这次股票拆分旨在符合纳斯达克的最低买盘价格要求，因为公司的股票价格先前曾跌破1.00美元的门槛。Exicure于2023年9月13日收到了纳斯达克的通知，了解到其未达到最低买盘价格要求，公司被给予到2024年9月9日重新符合要求的期限。该公司相信股票拆分将提高其普通股的市场流通性。截至2024年7月26日的记录股东将有权参加特别会议并投票。该公司还提供了有关股东如何参加虚拟会议并投票的信息。
总部位于伊利诺伊州芝加哥的生物技术公司Exicure, Inc. 宣布将于2024年8月15日以虚拟形式召开股东特别会议。会议的主要议程是征得股东批准修订公司修正章程，以实现普通股的股票拆分。所提议的股票拆分比率范围为1股转2股至1股转15股，具体比率由董事会自行决定。这次股票拆分旨在符合纳斯达克的最低买盘价格要求，因为公司的股票价格先前曾跌破1.00美元的门槛。Exicure于2023年9月13日收到了纳斯达克的通知，了解到其未达到最低买盘价格要求，公司被给予到2024年9月9日重新符合要求的期限。该公司相信股票拆分将提高其普通股的市场流通性。截至2024年7月26日的记录股东将有权参加特别会议并投票。该公司还提供了有关股东如何参加虚拟会议并投票的信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息